30-7513US DGP-A (FDA cleared)

Intended Use:

AESKULISA DGP IgA is a solid phase enzyme immunoassay for the quantitative and qualitative detection of IgA antibodies against deamidated Gliadin-specific peptides (DGP) in human serum.

Recombinant Antigens:

Deamidated gliadin-peptides

Native Antigens:

n.a.

Kit Configuration

Type: AESKULISA®
Method: Elisa
Reference: 30-7513US
Description: DGP-A (FDA cleared)
Kit Configuration: Single - A
Cut Off: 15
Range: 0 - 300 U/ml
Standard: -
Antibodies: IgA

Downloads